Reaction
Acquired Haemophilia reporting signals
As of the last recalculation, Acquired Haemophilia appears in 975 FAERS reports alongside 26 co-occurring drug terms. The strongest observed disproportionality signal is LOPERAMIDE HYDROCHLORIDE ORAL (PRR 29.7).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Loperamide Hydrochloride Oral | 14 | 29.7 | 29.7 |
| Alemtuzumab | 25 | 28.3 | 28.3 |
| Methocarbamol Tablets | 21 | 27.3 | 27.4 |
| Loperamide Hcl | 15 | 25.3 | 25.3 |
| Mometasone | 21 | 25.0 | 25.0 |
| Tamsulosin Hydrochloride | 22 | 23.5 | 23.5 |
| Lutetium Lu 177 Vipivotide Tetraxetan | 14 | 23.0 | 23.0 |
| Ceftriaxone | 34 | 22.9 | 22.9 |
| Cefuroxime | 11 | 20.8 | 20.8 |
| Methocarbamol | 21 | 20.2 | 20.2 |
| Ceftriaxone Sodium | 34 | 19.6 | 19.6 |
| Abiraterone Acetate | 34 | 18.2 | 18.3 |
| Clopidogrel Bisulfate | 78 | 17.6 | 17.6 |
| Erythropoietin | 16 | 16.9 | 16.9 |
| Ropinirole | 10 | 14.0 | 14.1 |
| Doxyclycline Hyclate | 11 | 13.9 | 13.9 |
| Oxazepam | 13 | 13.1 | 13.1 |
| Cyclophosphamide Injection, Solution | 86 | 11.3 | 11.3 |
| Cyclophosphamide | 86 | 11.3 | 11.3 |
| Cyclophosphamide For Injection | 86 | 11.3 | 11.3 |
| Ticagrelor | 15 | 10.2 | 10.2 |
| Brinzolamide | 4 | 9.9 | 9.9 |
| Abiraterone | 5 | 7.9 | 7.9 |
| Emicizumab | 4 | 6.9 | 6.9 |
| Polatuzumab Vedotin | 3 | 6.6 | 6.6 |
| Benralizumab | 5 | 5.4 | 5.4 |